For
Diabetes, Atherosclerosis And Aging
Could you use
more energy? Most 10-year-olds
are bursting with energy.
At age 30 most of us still have plenty of
energy. By 40 we're
beginning to slow down, but experience allows us shortcuts
to reduce our energy
needs. However by age 60, our
energy levels are so depleted that even the wisdom of
our years can't make up for our decline. If we make it to
80, we're just a shadow of our former selves. And if we
reach 100, we're thrilled just to be alive.
It's
not just our body as a whole that needs
energy it's our
individual cells as well. Our brain cells need
energy to think, our
heart cells need energy
to keep our blood circulating, our lung cells need
energy to process
oxygen, our kidney cells need
energy to excrete waste, our bone and muscle and
cells need energy for
structure and strength, and our immune cells need
energy to fight off
invading organisms.
Depletion of
Energy
Although most
diseases aren't caused by defects in the generation of
energy, they're all
characterized by energy
depletion. Cancer stroke, heart disease, diabetes, and
Alzheimer's disease are different in their origin and
expression, but they have one thing in common: depletion of
the energy-generating capacity of essential cells.
Energy depletion caused
by diseases produces feelings of weakness, lassitude,
depression, despair and hopelessness. Its endpoint is death.
As you know such
feelings don't just come from overt diseases. Lack of
energy is one of the
most common complaints in people of all ages Whether reduced
energy is caused by
subclinical disease states, unpleasant or traumatic
experiences, the "normal" ups and downs of life, or the
ravages of aging, the feelings are the same. No one
likes to feel weak. No one likes to be unable to do
things they need to do. No one likes to see life as dark,
colorless and unexciting. No one likes pain and suffering.
And no one likes to feel as if their life is slipping away
from them.
The Central
Failure In Human Life
The central
failure in human Iife is weakness: lack of strength; lack of
purpose; lack of character; and lack of will. The
appropriate reaction to weakness and feelings of inadequacy
is to build oneself up, but all too often people strive to
tear others down, or to rely on others for their self
esteem. The results in social terms have been personal
conflict, estrangement, war, and victimization.
Effects On Health
And Medical Care
The effects on
health and medical care have been reliance on doctors to
"cure" us rather than taking responsibility for our own
lives, the focus on the treatment of diseases rather than
their prevention, and the attempt to destroy our enemies
(viruses, bacteria, and other organisms) rather than to
maintain our youth, become stronger, and build up our
defenses.
A tragic example
of the failure of our medical system is the story of
Coenzyme Q, (CoQ10 )- an essential component of
our energy-generating system -- whose structure and function
was discovered in the United States in the late 1950s, but
whose role in health care has been almost totally ignored by
the U.S. medical establishment, except for the heroic
efforts of Dr. Karl Folkers of the University of Texas at
Austin.
The Discovery Of Coenzyme Q10
In 1956,
scientists at the University of Wisconsin under Dr. David E.
Green isolated a crystalline yellow compound from beef heart
mitochondria (the energy
factories of the cell). They gave a few milligrams of this
sample to Dr Folkers, who was head of a biochemical research
team at Merck Sharp And Dohme Research Laboratories in
Rahway, New Jersey.
Dr. Folkers and
his coworkers at Merck determined that the chemical
structure of CoQ is
2,3-dimethoxy-5-methly-6-decaprenyl-1,4-benzoquinone. This
structure was revealed at the International Congress on
Biochemistry in Vienna in 1958 and published that year in
the Journal of the American Chemical Society (60:4752).
FIGURE 1
Their discovery was given the name Coenzyme Q10
because it has the biochemical role of a coenzyme (it aids
in the action of enzymes) because the letter Q is the first
letter of the word quinone, and because it has 10 isoprenoid
units on its side chain (figure 1). Dr R.A. Morton and
associates at the University of Liverpool in England named
CoQ ubiquinone in their 1958 paper in Nature
(182:1764) because it is found in virtually every cell of
the body.
Concentration And
Biosynthesis Of CoQ
CoQ is found in
high concentrations (bound to three different proteins) in
the heart, liver kidney, and pancreas. The total body
content of CoQ has been estimated to be 0.5-1.5 grams. About
50% of the CoQ in the body is found within the mitochondria,
where energy is
generated on a continuous basis, and where CoQ has three
major functions: to help several mitochondrial enzymes
convert dietary nutrients (in the presence of oxygen) into
the energy "currency" of
the body ATP (Adenosine Triphosphate); to help quench some
of the free radicals generated in the
energy making process;
and to help protect the integrity of the mitochondrial
membrane.
CoQ levels have
been shown to be well below normal in patients with a wide
variety of diseases including heart disease, cancer and
muscular dystrophy, as well as in normally aging people. One
likely reason for these age and disease-related declines in
CoQ may be the complexity of the process by which CoQ is
synthesized within the body.
CoQ is
biosynthesized from the amino acids phenylalanine and
tyrosine with the help of at least eight vitamins and trace
elements (figure 2) all of which have vital biochemical
functions in the body in addition to the manufacture of CoQ.
Anyone with deficiencies of any of these nutrients is likely
to become deficient in CoQ. When you add the aging-related
breakdown of mitochondrial function which includes
unrepairable DNA mutations - it's no wonder that our bodies
hunger so much for this remarkable, life-enhancing nutrient.
Figure 2
The steps in the
sequence for the
biosynthesis of vitamin Q10 from
phenylalanine in the human body have
eight aromatic intermediates.
The Japanese Take The Lead
The fact that CoQ
is available in the United States today to prevent killer
diseases and extend lifespan in because of pioneering
efforts in Japan in the 1970s. For 16 years after is
discovery, even exploratory clinical studies with CoQ were
extraordinary restricted because there was so little of it
available from organic sources. (CoQ is found in virtually
all foods and human and animal tissues, but is difficult and
costly to extract it these sources). This began to change
1974 when the Japanese Nisshin began industrial production
of CoQ from on an ingredient in tobacco, which led to the
production of hundred of kilograms of the nutrient. This was
used in clinical trials by the Eisai company, and was
followed by the development of fermentation methods to
synthesize CoQ in 1977 by the Kanegafuchi company, which
also conducted clinical research. There also has been in
Western countries, such as the determination of CoQ works,
for which English scientist Dr. Peter Mitchell was awarded
the Nobel Prize.
Approval Of CoQ
In Japan
These
developments led to the approval (in the 1970s) of Coenzyme
Q10, in Japan (under the trade name Ubidecarenono) as a
treatment for people with cardiovascular diseases. By 1982,
CoQ had become one of the top 5 selling drugs in Japan, with
about 6 million Japanese taking it on a regular basis. CoQ
continues to be a top-selling drug in Japan. Its use there
is primarily as a drug for the treatment of specific
conditions such as heart failure, cardiac arrhythmias, and
hypertension (high blood pressure).
Although CoQ is
highly effective in treating these diseases, its enormous
potential as an anti-aging, anti-disease therapy has
remained largely untapped because of the prevailing dogma in
medical circles against the concept of an all purpose,
health-building therapy and because of the bias in Western
medicine that favors the development proprietary medicines
that can be patented and protected against competition. Dr.
Folkers pointed this out in 1986 in his acceptance speech,
after being awarded the prestigious Priestly Medal for his
research into CoQ and other nutrients by the American
Chemical Society. "The reason CoQ is not a 'household
nutrient' in the West," said Dr. Folkers, "has more to do
with the lack of protected marketing positions, than its
safety or how well it works."
The Foundation
Introduces CoQ Into The U.S.
The fact that CoQ
is now sold openly as a nutrient in the U.S. is the direct
result of an article ("Life Extension Benefits of Coenzyme
Q10") by Gregory M.Fahy, Ph.D. in the July 1983 issue of The
Life Extension Foundation's newsletter Anti-Aging News. This
pioneering, "inside" article introduced CoQ into the United
States. Its rundown of the voluminous scientific evidence
(even then) that CoQ is essential for health and longevity
was a revelation to Foundation members (and other Americans)
who had never before heard of this remarkable nutrient.
More than half of
Dr Fahy's article dealt with how readers might try to obtain
CoQ and how if that proved impossible, they might raise
their CoQ levels by supplementing their diet with the
nutrient precursors of CoQ. At the time, the only source of
CoQ in the U.S. was a Texas company that only offered small
doses of CoQ at exceedingly high prices to select customers.
Another company
in Maryland wanted to gain FDA approval in the U.S. as a
cardiovascular drug, but hadn't yet raised enough capital to
start clinical trials.
The primary
worldwide sources of CoQ were the Japanese companies who had
developed it, but they were primarily interested in seeing
CoQ gain approval in the U.S. as a drug, as had been done
Japan. None of them were especially interested in having CoQ
sold as nutrient in this country because of their fear that
the FDA would ban it as an "unapproved new drug".
Dr. Fahy's
Meetings With Japanese Company Officials
The turning point
came when Dr. Fahy set up several meetings with officials of
the Japanese companies producing CoQ in an attempt to
persuade them of the value of providing CoQ to companies who
wished to sell it as a nutrient. Dr Fahy pointed out the
enormous potential of CoQ as a disease-preventing,
anti-aging therapy and tried to allay their fears about FDA
intervention by focusing on the extraordinary safety of CoQ,
which could be used, he suggested, to attempt to "persuade"
the FDA from banning it. Since the Japanese were well aware
of the safety of CoQ (because of the millions of consumers
of CoQ in Japan) as well as its remarkable health benefits,
they relented and decided to sell it to American companies.
Since then, the
use of CoQ as a nutrient has grown by leaps and bounds in
the United States. CoQ is now sold in health food stores
around the country, and by many mail order companies. It is
one of the most popular products sold through The Foundation
and grows in popularity every year. We've introduced several
CoQ products over the years, with the latest being
Prolongevity's oil-based, soft-gel version of CoQ, which has
shown greater bioavailability than dry versions of CoQ.
Although CoQ is
now freely available in the U.S, the number of Americans
enjoying the health benefits of CoQ is ridiculously small.
Hundreds of research studies and clinical trials have
demonstrated dozens of invaluable health and medical
benefits for CoQ, with little or no toxicity reported, even
at doses of hundreds of milligrams per day. The evidence
strongly supports the proposition that every
American could benefit from daily, supplemental CoQ, and
that the regular, widespread use of this remarkable nutrient
among Americans would save vast numbers of lives!
What follows is a
rundown of the multiple health benefits of CoQ, based upon
the latest published studies in the medical literature.
The Multiple
Health and Longevity Benefits of CoQ
Among the
documented health and longevity benefits of CoQ are the:
-
Generation of
energy in every cell
tissue, and organ of the body;
-
Prevention and
treatment of a wide variety of cardiovascular diseases,
including congestive heart failure, angina pectoris (heart
pain), cardiac arrhythmias, high blood pressure, and
atherosclerosis;
-
Prevention and
treatment of cancer of the breast, lung, colon, prostate,
and other types of cancer;
-
Treatment of
several types of muscular dystrophy;
-
Treatment of
periodontal disease;
-
Protection
against ischemic damage from accidents and surgical
procedures, especially in the heart;
-
Protection
against the side effects of toxic drugs;
-
Protection
against the cellular damage of excessive free radical
activity;
-
Slowing of
various aspects of the aging process leading to the
extension of mean lifespan (in animal studies).
Now let's take a
closer look at some exciting studies that document the
extraordinary health benefits of coenzyme Q10.
How Coenzyme Q10
Helps To Generate Energy
Your body is made
up of 100 trillion or so cells, all of which must produce
their own energy to
carry out their essential life functions. In order to
generate this energy
your cells have factories (called mitochondria) where
nutrients obtained from food are "burned" in the presence of
oxygen obtained from the air we breath. An estimated 96% of
the oxygen we consume is used solely for the generation of
energy!
Coenzyme Q, is a
necessary component of this energy-generating process in
every cell of your body. No other substance can be
substituted for CoQ, without which
energy cannot be
generated and life cannot be sustained! Here is how the
process works:
The molecules in
the food you eat are broken down into smaller units
containing carbon atoms held together by negatively charged
electrons. The bonds between the carbon atoms are then
broken down further, so that the electrons are released. The
energy built into these
released electrons is converted in ATP, which the cells use
as their energy
currency. The depleted electrons are then charged protons
and oxygen to form water-harmless waste product of the
process.
CoQ's Role In The
Process
CoQ molecules
assist several enzymes that stimulate this energy-generating
process by acting as a shuttle to transport both electrons
and protons from one bioenergy enzyme to another. Each CoQ
molecule carries electrons and protons from donor enzymes to
acceptor enzymes. They then return to pick up more electrons
and protons. The CoQ transport cycle is repeated
over-and-over again, thousands of times a second! Every
electron and proton from which
energy is to be extracted must first be transported
to that appropriate enzyme by a molecule of Coenzyme Q10
An
Effective Therapy For Cardiovascular Disease
The use of CoQ to
prevent and treat cardiovascular diseases is the oldest and
most documented health benefit provided by CoQ. There have
been dozens of studies demonstrating that CoQ can prefect
the heart against damage from reduced blood flow and
electrical disturbances, and that patients with heart pain,
heart arrhythmias, congestive heart failure, heart valve
problems, hypertension, and heart damage caused by toxic
drugs such as adriamycin can be improved significantly in
some cases dramatically by treatment with CoQ.
A number of
proposed therapeutic mechanisms of action for CoQ in
cardiovascular disease can be found in TABLE 1. However
there's little doubt that the basic, underlying mechanism of
action for CoQ's cardiovascular benefits is its role in the
generation of energy.
Animal hearts pretreated with CoQ show substantially less
depletion of ATP than untreated hearts. Ultrastructural
studies show that hearts pretreated with CoQ maintain
mitochondrial architecture within their cells far better
than untreated control hearts, and that CoQ stabilizes and
strengthens heart cell membranes, improves the heart's
mechanical peformance, protects the heart against free
radical damage, and keeps heart cells alive (in tissue
culture) far longer than untreated cells.
Clinical Heart
Failures Studies With CoQ
The rationale for
using CoQ in the treatment of patients with congestive heart
failure comes from studies showing that blood and tissue
levels of CoQ in more than 1,000 heart attack patients were
significantly lower than normal. In one study it was shown
that the most favorable clinical response to CoQ was in
patients with the lowest blood levels of CoQ.
There have been
more than 31 reports of clinical trials in Japan describing
the favorable effects of either intravenous or oral CoQ
therapy in patients with heart failure from various causes.
Some of these trials used CoQ by itself, in others CoQ was
used in addition to conventional therapies such as
digitalis, diuretics, and vasodilators.
In one controlled
trial, 12 patients who failed to get relief from diuretics
and digitalis were given 100 mg daily of oral CoQ. After 30
days, 67% of the patients showed clinical improvement in
their symptoms, including dyspnea (breathing problems) and
fatigue. There was also a significant reduction in left
atrial size, an indication of improved heart performance.
In a
placebo-controlled, double blind, crossover trial, 19
patients with advanced heart failure were treated with 33 mg
of CoQ three times a day for 12 weeks. The result showed
significant improvement in cardiac function during CoQ
treatment as compared to controls in such functions as
ejection fraction, stroke volume, and contractibility.
Although the
results of these trials are highly persuasive, they were all
relatively small in size. In the last few years, however,
the results of a large multicenter trial of CoQ in heart
failure patients in Italy have been published in several
journals.
Table 1
|
Possible Therapeutic Mechanisms of Coenzyme Q10
Cardiovascular Disease |
|
1.
Correction of CoQ deficiency state. |
|
2.
Direct free radical scavenger via semiquinone species. |
|
3.
Direct membrane stabilizing activity due to phospholipid
protein interactions. |
|
4.
Correction of mitochondrial "leak" of electrons during
oxidative respiration. |
|
5.
Induction of DT diaphorase. |
|
6.
Possible effects on prostaglandin metabolism. |
|
7.
Inhibition of intracellular phospholipases. |
|
8.
Preservation of myocardial Na+- K+
ATPase activity. |
|
9.
Stabilization of integrity of Ca+2dependent
slow channels. |
Italian
Multicenter Study
The Italian study
looked at CoQ as an adjunct to conventional drugs in 2,664
heart patients in 173 clinical centers over a 3-month
period. The daily dosage of CoQ was 50-150 mg daily with the
majority of patients (78%) receiving 100 mg/day. The
patients in the study were all rated Class II and III
(moderately ill) according to a rating scale based upon the
guidelines formulated by the New York Heart Association (NYHA)
regarding the symptoms associated with congestive heart
failure.
The results
showed improvement in virtually all functions measured in
the CoQ-treated patients. The proportions of patients
exhibiting significant improvement (of at least one point)
in clinical symptoms was as follows (Tables 2 and 3):
cyanosis 78.1%, edema 78.6%, pulmonary rate 77.8%,
enlargement of liver 49.3%, jugular reflex 71.8%, dyspnoea
52.7%, palpitations 75.4%, sweating 79.8%, arrhythmias
63.4%, insomnia 66.8%, and vertigo 73.1%. They also found
significant improvement in at least three symptoms in 54% of
the patients, indicating major improvement in the quality of
their lives.
The investigators
summed up their results as follows:
"A significant reduction in blood
pressure and heart rate, both in supine and sitting
position, was observed in our study. These data confirm the
results of a recent study in which CoQ, therapy led to a
reduction in peripheral vascular resistance, resulting in a
significant decrease in blood pressure. An inhibitory effect
of CoQ10 on plasma catecholamine levels in heart
failure has been recently reported. In our patients, the
reduction in peripheral vascular resistance may be related
to an inhibition by CoQ, of the sympathetic overactivity
known to be present early in heart failure. The reduction in
sweating and palpitations, reported by our patients may
result from the same mechanism."
Table 2
Clinical Signs Assessment Results
|
Description
|
Present
at baseline(n)
|
Improved at
least
1 point after 3
months of CoQ10
treatment (%)
|
Statistical
signifiance
of score
variations*
|
|
Cyanosis
|
675
|
78.67
|
P<0.01
|
|
Odema
|
1764
|
78.06
|
P<0.01
|
|
Pulmonary
Rates
|
1752
|
77.85
|
P<0.01
|
|
Enlargement
of liver area
|
1285
|
49.26
|
P<0.01
|
|
Jugular
reflux
|
713
|
71.81
|
P<0.01
|
* Wilcoxon
signed-rank
Table 3
Clinical
Symptoms Assessment Results
|
Description
|
Present
at baseline(n)
|
Improved at
least
1 point after 3
months of CoQ10
treatment (%)
|
Statistical
signifiance
of score
variations*
|
|
Dyspnoea
|
2163
|
52.75
|
P<0.01
|
|
Palpitations
|
1903
|
75.46
|
P<0.01
|
|
Sweating
|
1044
|
79.79
|
P<0.01
|
|
Subjective
arrhythima
|
1143
|
63.43
|
P<0.01
|
|
Insomnia
|
1597
|
62.87
|
P<0.01
|
|
Dizziness
|
1282
|
73.13
|
P<0.01
|
|
Nocturia
|
1541
|
53.67
|
P<0.01
|
* Wilcoxon
signed-rank
Treatment Of
Hypertension With CoQ
We've been
recommending CoQ to patients with cardiovascular disease for
years with very good results. Most of these patients start
taking CoQ in addition to the conventional drugs they are
using. In many cases, they find that prolonged use of CoQ
eliminates their need for such prescription drugs, A recent
study of the use of CoQ in patients suffering from
hypertension (high blood pressure) showed how CoQ can' help
patients dispense with their drugs.
This study was
conducted by scientists (including Karl Folkers) at the
University of Texas at Austin. A total of 109 patients with
hypertension were given a variable dose of from 75 to 360
mg/day of CoQ in addition to the existing drug regimen. The
patients were followed closely with frequent clinic visits
to record blood pressure and make the necessary adjustments
in dosage. No side effects or drug interactions were found
in any of the patients in the study.
Figure 3
They found that mean systolic blood pressure improved from
159 to 147 and mean diastolic blood pressure improved from
94 to 85 (Figure 3). They also found that, as the patients'
functional status and blood pressure improved, and there was
a gradual decrease in the need far antihypertensive drugs.
Thirty-seven percent of the patients were able to
discontinue one drug, 11% discontinued two drugs, and 4%
discontinued three drugs. The average time before stopping
an anti- hypertensive drug was 4.4 months after starting CoQ,
with 62% requiring 3 or more months (Figure 4).
Figure 4
They concluded
that:
"CoQ, a both remarkably safe and cost effective and should
be considered among the initial therapeutic modalities
alongside such fundamental recommendations as diet exercise
and stress reduction and should certainly be considered
prior to embarking upon on escalating course of
pharmacologic interventions with all of their well
established medical and economic hazards."
Interestingly,
the Texas scientists found that the most effective way of
raising blood levels of CoQ in patients was to give it with
a fat containing food (usually peanut butter), which
"more than doubled the blood CoQ level on any given dosage."
This is not surprising because CoQ is a fat-soluble nutrient
that assimilates better in the presence of fat. For this
reason, The Foundation now offers CoQ in oil-based, soft-gel
capsules, which maximizes its bioavailability within the
body.
The
Bioavaliability of CoQ
Recent studies at
the Royal Danish School of Pharmacy in Denmark have
demonstrated that "CoQ in soy bean oil in soft gelatine
capsules has higher bioavailability than CoQ formulated with
other inert substances." These studies compared CoQ in dry
powder form (in capsules) and in tablets with various
oil-based formulations of CoQ. It is on the basis of these
studies that we now offer CoQ in the same soy-bean-oil
formula shown in these studies to produce optimal absorption
of CoQ into the body. For further information about this
product or to order CoQ10 On-line.